Eli Lilly and Co said on Tuesday that the government-sponsored clinical trial of its COVID-19 antibody treatment similar to one taken by U.S. President Donald Trump has been paused because of a safety concern.
This report produced by Jillian Kitchener.
Regeneron said on Wednesday its coronavirus antibody cocktail - used to treat U.S. President Donald Trump - significantly reduced..
Drug maker Eli Lilly is hitting pause on a clinical trial for a coronavirus treatment; CBS2's Dick Brennan reports.
